Found 29 results
Author Keyword Title [ Type(Desc)] Year
Filters: Author is van Breemen, Richard B  [Clear All Filters]
Journal Article
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Muchiri RN, van Breemen RB.  2020.  Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.. J Mass Spectrom. :e4647.
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.
van Breemen RB, Simchuk D.  2023.  Antiviral activities of hemp cannabinoids.. Clin Sci (Lond). 137(8):633-643.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
van Breemen RB, Hathout Y, Fabris D.  2020.  Catherine Fenselau: A distinguished career dedicated to biomedical mass spectrometry.. J Mass Spectrom. 55(2):e4500.
van Breemen RB, Hathout Y, Fabris D.  2020.  Catherine Fenselau: A distinguished career dedicated to biomedical mass spectrometry.. J Mass Spectrom. 55(2):e4500.
Rasin A, Devgun JM, Nosal DG, Meehan TJ, van Breemen RB, Thompson TM.  2019.  Coagulopathy After Synthetic Cannabinoid Use: A Case Report.. Ann Intern Med.
Gaba RC, Khabbaz RC, Muchiri RN, Morrison JD, Elkhadragy L, Totura WM, Samuelson JP, Whiteley HE, Deaton RL, Nguyen PL et al..  2021.  Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model.. Drug Deliv Transl Res.
Muchiri RN, van Breemen RB.  2021.  Drug discovery from natural products using affinity selection-mass spectrometry.. Drug Discov Today Technol. 40:59-63.
Feinstein DL, Nosal DG, Ramanathan S, Zhou J, Chen L, Hershow RC, van Breemen RB, Wright E, Hafner JW, Rubinstein I.  2019.  Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.. Clin Toxicol (Phila). :1-9.
Feinstein DL, Nosal DG, Ramanathan S, Zhou J, Chen L, Hershow RC, van Breemen RB, Wright E, Hafner JW, Rubinstein I.  2020.  Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.. Clin Toxicol (Phila). 58(7):716-724.
Wang S, Dunlap TL, Huang L, Liu Y, Simmler C, Lantvit DD, Crosby J, Howell CE, Dong H, Chen S-N et al..  2018.  Evidence for Chemopreventive and Resilience Activity of Licorice: and G. Extracts Modulate Estrogen Metabolism in ACI Rats.. Cancer Prev Res (Phila). 11(12):819-830.
Fang J-B, Nikolic D, Lankin DC, Simmler C, Chen S-N, Alvarenga RFRamos, Liu Y, Pauli GF, van Breemen RB.  2019.  Formation of (2)- and (2)-8-Prenylnaringenin Glucuronides by Human UDP-Glucuronosyltransferases.. J Agric Food Chem. 67(42):11650-11656.
Chen L, Nikolic D, Li G, Liu J, van Breemen RB.  2023.  In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC.. Toxicol Sci. 196(1):16-24.
Rue EA, Glinski JA, Glinski VB, van Breemen RB.  2019.  Ion mobility-mass spectrometry for the separation and analysis of procyanidins.. J Mass Spectrom.
Burton TCJ, Lankin DC, Nikolic D, Guo B, Ju J, Dietz BM, Che C-T, Soejarto DDjendoel, van Breemen RB.  2021.  Isolation and elucidation of two isoflavonoids from an American Indian plant, Pursh, using Magnetic Microbead Affinity Selection Screening (MagMASS) for estrogen receptor alpha ligands.. Phytochem Lett. 45:110-116.
Bolton JL, Dunlap TL, Hajirahimkhan A, Mbachu O, Chen S-N, Chadwick L, Nikolic D, van Breemen RB, Pauli GF, Dietz BM.  2019.  The Multiple Biological Targets of Hops and Bioactive Compounds.. Chem Res Toxicol. 32(2):222-233.
Chen L, Choi J, Leonard SW, Banuvar S, Barengolts E, Viana M, Chen S-N, Pauli GF, Bolton JL, van Breemen RB.  2020.  No Clinically Relevant Pharmacokinetic Interactions of a Red Clover Dietary Supplement with Cytochrome P450 Enzymes in Women.. J Agric Food Chem. 68(47):13929-13939.
van Breemen RB, Chen L, Tonsing-Carter A, Banuvar S, Barengolts E, Viana M, Chen S-N, Pauli GF, Bolton JL.  2020.  Pharmacokinetic Interactions of a Hop Dietary Supplement with Drug Metabolism in Perimenopausal and Postmenopausal Women.. J Agric Food Chem. 68(18):5212-5220.
van Breemen RB, Chen L, Tonsing-Carter A, Banuvar S, Barengolts E, Viana M, Chen S-N, Pauli GF, Bolton JL.  2020.  Pharmacokinetic Interactions of a Hop Dietary Supplement with Drug Metabolism in Perimenopausal and Postmenopausal Women.. J Agric Food Chem.
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Fança-Berthon P, Tenon M, Le Bouter-Banon S, Manfré A, Maudet C, Dion A, Chevallier H, Laval J, van Breemen RB.  2021.  Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study.. J Nutr.

Pages